Connecticut public health officials advised vaccine providers Saturday to resume use of the Johnson & Johnson COVID-19 shot after a federal review concluded its benefits outweighed the risk of a rare blood clotting condition. The guidance followed a Friday decision by the Centers for Disease Control and U.S. Food and Drug Administration, ending an 11-day […]
